Synthesis and Evaluation of 5-(3-(Pyrazin-2-yl)benzylidene)thiazolidine-2,4-dione Derivatives as Pan-Pim Kinases Inhibitors

被引:15
作者
Lee, Jinho [1 ]
Park, Jongseong [1 ]
Hong, Victor Sukbong [1 ]
机构
[1] Keimyung Univ, Dept Chem, Taegu 704701, South Korea
关键词
Pim-1; Pim-2; Pim-3; 5-benzylidenethiazolidine-2,4-dione; pan-pim kinase inhibitor; C-MYC; SERINE/THREONINE KINASES; TRANSGENIC MICE; PROTEIN-KINASES; N-MYC; DISCOVERY; POTENT; TUMORS;
D O I
10.1248/cpb.c14-00325
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pim kinases play a key role in the regulation of signaling pathways including proliferation, migration, and metabolism and are a potential target for cancer therapy. A series of 5-benzylidenethiazolidine-2,4-diones were synthesized as pim kinase inhibitors. The structure-activity relationships (SAR) of the analogues in inhibiting in vitro pim kinase activity as well as the proliferation of leukemia cell lines were examined. SAR studies indicated that a hydroxyl group at the 2-position of the benzene ring of 5-benzylidenethiazolidine-2,4-dione plays an important role in the inhibitory activity against all three pim kinases and replacement with a pyrazinyl group at the 5-position of the benzene ring of 5-benzylidenethiazolidine-2,4-dione improved activity significantly. The compounds exerted anti-proliferative activity against the three leukemia cell lines we tested. The most potent compound, 5i, had an EC50 value of 0.8 mu m in the MV4-11 cell line. The result of kinase profiling indicated that compound Si was highly selective for pim-kinases.
引用
收藏
页码:906 / 914
页数:9
相关论文
共 50 条
  • [21] Development of novel thiazolidine-2,4-dione derivatives as PPAR-γ agonists through design, synthesis, computational docking, MD simulation, and comprehensive in vitro and in vivo evaluation
    Srinivasa, Mahendra Gowdru
    Revanasiddappa, B. C.
    Prabhu, Ashwini
    Rani, Vinitha
    Ghate, Sudeep D.
    Kumar, B. R. Prashantha
    RSC MEDICINAL CHEMISTRY, 2023, 14 (11): : 2401 - 2416
  • [22] Design, synthesis, in-vitro, in-vivo and ex-vivo pharmacology of thiazolidine-2,4-dione derivatives as selective and reversible monoamine oxidase-B inhibitors
    Jadoon, Ridha
    Javed, Muhammad Aamir
    Jan, Muhammad Saeed
    Ikram, Muhammad
    Mahnashi, Mater H.
    Sadiq, Abdul
    Shahid, Muhammad
    Rashid, Umer
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 76
  • [23] Exploration of Some Thiazolidine-2,4-dione and 2-Oxoindoline Derivatives Incorporating 3,4,5-trimethoxybenzyl Moiety as Novel Anticancer Agent
    Le Cong Huan
    Hai Pham-The
    Huong Le-Thi-Thu
    Tran Phuong Thao
    Do Nguyet Que
    Nguyen-Thu Trang
    Phan Thi Phuong Dung
    Pyo, Minji
    Sang-Bae Han
    Nguyen Thi Thuan
    Nguyen-Hai Nam
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (04) : 375 - 387
  • [24] Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases
    Dakin, Les A.
    Block, Michael H.
    Chen, Huawei
    Code, Erin
    Dowling, James E.
    Feng, Xiaomei
    Ferguson, Andrew D.
    Green, Isabelle
    Hird, Alexander W.
    Howard, Tina
    Keeton, Erika K.
    Lamb, Michelle L.
    Lyne, Paul D.
    Pollard, Hannah
    Read, Jon
    Wu, Allan J.
    Zhang, Tao
    Zheng, Xiaolan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4599 - 4604
  • [25] Synthesis of 1,2,4-Triazoles and 1,3,4-Thiadiazinones by [3+2] and [3+3] Domino Annulation Reactions of Nitrile Imines with Succinimide and Thiazolidine-2,4-dione
    Chilaka, Sai Krishna
    Chinthapally, Krishna Prasad
    Soda, Anil Kumar
    Chellu, Ramesh Kumar
    Kurva, Srinivas
    Nanubolu, Jagadeesh Babu
    Madabhushi, Sridhar
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2023, 12 (04)
  • [26] Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)
    Shi, Yan
    Wang, Ying
    Meng, Wei
    Brigance, Robert P.
    Ryono, Denis E.
    Bolton, Scott
    Zhang, Hao
    Chen, Sean
    Smirk, Rebecca
    Tao, Shiwei
    Tino, Joseph A.
    Williams, Kristin N.
    Sulsky, Richard
    Nielsen, Laura
    Ellsworth, Bruce
    Wong, Michael K. Y.
    Sun, Jung-Hui
    Leith, Leslie W.
    Sun, Dawn
    Wu, Dauh-Rurng
    Gupta, Anuradha
    Rampulla, Richard
    Mathur, Arvind
    Chen, Bang-Chi
    Wang, Aiying
    Fuentes-Catanio, Helen G.
    Kunselman, Lori
    Cap, Michael
    Zalaznick, Jacob
    Ma, Xiaohui
    Liu, Heng
    Taylor, Joseph R.
    Zebo, Rachel
    Jones, Beverly
    Kalinowski, Stephen
    Swartz, Joann
    Staal, Ada
    O'Malley, Kevin
    Kopcho, Lisa
    Muckelbauer, Jodi K.
    Krystek, Stanley R.
    Spronk, Steven A.
    Marcinkeviciene, Jovita
    Everlof, Gerry
    Chen, Xue-Qing
    Xu, Carrie
    Li, Yi-Xin
    Langish, Robert A.
    Yang, Yanou
    Wang, Qi
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (05) : 4291 - 4317
  • [27] Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors
    Liang, Xiao
    Fu, Huansheng
    Xiao, Peng
    Fang, Hao
    Hou, Xuben
    BIOORGANIC CHEMISTRY, 2020, 103
  • [28] Synthesis, Design and Anti-inflammatory Activity of Novel 5-(Indol-3-yl)thiazolidinone Derivatives as COX-2 Inhibitors
    Atta-Allah, Saad R.
    Ismail, Nasser S. M.
    Nassar, Ibrahim F.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (06) : 525 - 541
  • [29] Design, Synthesis and Biological Evaluation of 3-(3,4,5-Trimethoxyphenyl)-5-(2-(5-arylbenzo[b]thiophen-3-yl)oxazol-5-yl)isoxazole Derivatives as Anticancer Agents
    Prcmalatha, Syndla
    Rambabu, G.
    Hatti, Islavathu
    Ramachandra, Dittakavi
    LETTERS IN ORGANIC CHEMISTRY, 2020, 17 (05) : 345 - 351
  • [30] Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents
    Zhang, Fei
    Wang, Xiao-Liang
    Shi, Jing
    Wang, She-Feng
    Yin, Yong
    Yang, Yu-Shun
    Zhang, Wei-Ming
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (01) : 468 - 477